Immunization with proline rich region of pneumococcal surface protein A has no role in protection against Streptococcus pneumoniae serotype 19F

2020 ◽  
Vol 138 ◽  
pp. 103761 ◽  
Author(s):  
Michael M. Girgis ◽  
Abeer M. Abd El-Aziz ◽  
Ramadan Hassan ◽  
Youssif M. Ali
Vaccines ◽  
2015 ◽  
Vol 3 (4) ◽  
pp. 850-874 ◽  
Author(s):  
Marco Tamborrini ◽  
Nina Geib ◽  
Aniebrys Marrero-Nodarse ◽  
Maja Jud ◽  
Julia Hauser ◽  
...  

2006 ◽  
Vol 55 (4) ◽  
pp. 375-378 ◽  
Author(s):  
Daniela M. Ferreira ◽  
Eliane N. Miyaji ◽  
Maria Leonor S. Oliveira ◽  
Michelle Darrieux ◽  
Ana Paula M. Arêas ◽  
...  

Pneumococcal surface protein A (PspA) is a promising candidate for the development of cost-effective vaccines against Streptococcus pneumoniae. In the present study, BALB/c mice were immunized with DNA vaccine vectors expressing the N-terminal region of PspA. Animals immunized with a vector expressing secreted PspA developed higher levels of antibody than mice immunized with the vector expressing the antigen in the cytosol. However, both immunogens elicited similar levels of protection against intraperitoneal challenge. Furthermore, immunization with exactly the same fragment in the form of a recombinant protein, with aluminium hydroxide as an adjuvant, elicited even higher antibody levels, but this increased humoral response did not correlate with enhanced protection. These results show that DNA vaccines expressing PspA are able to elicit protection levels comparable to recombinant protein, even though total anti-PspA IgG response is considerably lower.


2013 ◽  
Vol 46 (3) ◽  
pp. 180-186 ◽  
Author(s):  
Masura Mohd Yatim ◽  
Siti Norbaya Masri ◽  
Mohd Nasir Mohd Desa ◽  
Niazlin Mohd Taib ◽  
Syafinaz Amin Nordin ◽  
...  

Vaccine ◽  
2007 ◽  
Vol 25 (6) ◽  
pp. 1030-1035 ◽  
Author(s):  
Christiane Heeg ◽  
Carmen Franken ◽  
Mark van der Linden ◽  
Adnan Al-Lahham ◽  
Ralf René Reinert

Sign in / Sign up

Export Citation Format

Share Document